transferrin has been researched along with Acute Relapsing Multiple Sclerosis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| LeVine, SM; Sands, SA; Tsau, S | 1 |
| Bourantas, KL; Chaidos, A; Dalamaga, A; Hatzimichael, EC; Kosma, K; Makis, AC; Sfagos, C | 1 |
| Adam, P; Andel, J; Andel, M; Kalistová, H; Kelbich, P; Sobek, O; Zeman, D | 1 |
3 other study(ies) available for transferrin and Acute Relapsing Multiple Sclerosis
| Article | Year |
|---|---|
The habenula and iron metabolism in cerebral mouse models of multiple sclerosis.
Topics: Animals; Encephalomyelitis, Autoimmune, Experimental; Female; Habenula; Iron; Iron Regulatory Protein 1; Iron Regulatory Protein 2; Mice, Inbred C57BL; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Receptors, Transferrin; Transferrin | 2015 |
Serum ferritin, transferrin and soluble transferrin receptor levels in multiple sclerosis patients.
Topics: Adult; Biomarkers; Female; Ferritins; Humans; Iron; Male; Middle Aged; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Oxidative Stress; Receptors, Transferrin; Severity of Illness Index; Solubility; Transferrin | 2005 |
Transferrin in patients with multiple sclerosis: a comparison among various subgroups of multiple sclerosis patients.
Topics: Age Factors; Analysis of Variance; Antioxidants; Blood-Brain Barrier; Female; Humans; Male; Multiple Sclerosis; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Severity of Illness Index; Transferrin | 2000 |